CLINICAL IMMUNOLOGY AND n n
SEROLOGY EXAM | NEWEST ACTUAL EX n n n n n
AM COMPREHENSIVE QUESTIONS AND
n n n n
VERIFIED ANSWERS GRADED A+ |100% n n n n n n
CORRECT | 2024 UPDATE!! n n n
1. Which of the following responses is the type of allograft rejectio
n n n n n n n n n n n
n associated with vascular and parenchymal injury withlymphocyt
n n n n n n n n
e infiltrates ?
n n
b . Acute cellular rejection
n n n n
Which of the following is an example of a tumor specificanti
n n n n n n n n n n n
gen ? n
a . BCR / ABL fusion protein
n n n n n n
Both AFP and hCG exhibit serum elevations in in
n n n n n n n n
b. ovarian germ cell carcinoma
n n n n
,All of the following are recommended for cancer screening inth
n n n n n n n n n n
e groups indicated except
n n n
a . CA 125 / women of reproductive age .
n n n n n n n n n
The best use of serum tumor markers is considered to be in
n n n n n n n n n n n
c . monitoring patients undergoing cancer treatment
n n n n n n
Which of the following markers could be elevated innonmalignant
n n n n n n n n n n
liver disease ?n n
d . All of the above
n n n n n
A woman with breast cancer is treated with a mono clonala
n n n n n n n n n n n
ntibody to HER2 . This is an example of
n n n n n n n n
c . passive immunotherapy
n n n
,8. Which immunosuppressive agent selectively inhibits IL -
n n n n n n n
2 receptor -
n n n
mediated activation of T cells and causes clearanceof activated
n n n n n n n n n n
T cells from the circulation ?
n n n n n n
d . Daclizumab
n n
Which one of the following donors would be expected to elicit apo
n n n n n n n n n n n n
sitive mixed lymphocyte response in lymphocytes from a patient
n n n n n n n n n
who has the HLA - DRB1 * 01 : 01 01:03 alleles ?
n n n n n n n n n n n n
c. DRB1 * 01 : 03 , 01:03
n n n n n n n
14. Which of the following HLA antigens would be ex pected toeli
n n n n n n n n n n n n
cit an HLA antibody response in a kidney transplant recipientwit
n n n n n n n n n n
h the following HLA type : HLA - A 01,03 ; B 07,14 ; C 01,04N
n n n n n n n n n n n n n n n
; DRB1 16,07 ?
n n n
c . HLA - C * 04
n n n n n n
syngeneic graft n
isograft; identical twins n n
, allograft
transplantation of healthy tissue from one person to anotherpers
n n n n n n n n n
on; also called homograft
n n n
same species n
xenograft
transplantation (dermis only) from a foreign donor (usually ap
n n n n n n n n n
ig) and transferred to a human; also called heterograft
n n n n n n n n
Direct allorecognition
n
recipient cytotoxic T cells from host bind and respond directlyt
n n n n n n n n n n
o foreign (allo) HLA proteins MHC I on graft cells.
n n n n n n n n n
CD8
mixed lymphocyte reaction (MLR)
n n n
in vitro reaction of alloreactive T cells from one individual agai
n n n n n n n n n n
nst major histocompatibility complex (MHC) antigens onbloo
n n n n n n n
d cells from another individual
n n n n
SEROLOGY EXAM | NEWEST ACTUAL EX n n n n n
AM COMPREHENSIVE QUESTIONS AND
n n n n
VERIFIED ANSWERS GRADED A+ |100% n n n n n n
CORRECT | 2024 UPDATE!! n n n
1. Which of the following responses is the type of allograft rejectio
n n n n n n n n n n n
n associated with vascular and parenchymal injury withlymphocyt
n n n n n n n n
e infiltrates ?
n n
b . Acute cellular rejection
n n n n
Which of the following is an example of a tumor specificanti
n n n n n n n n n n n
gen ? n
a . BCR / ABL fusion protein
n n n n n n
Both AFP and hCG exhibit serum elevations in in
n n n n n n n n
b. ovarian germ cell carcinoma
n n n n
,All of the following are recommended for cancer screening inth
n n n n n n n n n n
e groups indicated except
n n n
a . CA 125 / women of reproductive age .
n n n n n n n n n
The best use of serum tumor markers is considered to be in
n n n n n n n n n n n
c . monitoring patients undergoing cancer treatment
n n n n n n
Which of the following markers could be elevated innonmalignant
n n n n n n n n n n
liver disease ?n n
d . All of the above
n n n n n
A woman with breast cancer is treated with a mono clonala
n n n n n n n n n n n
ntibody to HER2 . This is an example of
n n n n n n n n
c . passive immunotherapy
n n n
,8. Which immunosuppressive agent selectively inhibits IL -
n n n n n n n
2 receptor -
n n n
mediated activation of T cells and causes clearanceof activated
n n n n n n n n n n
T cells from the circulation ?
n n n n n n
d . Daclizumab
n n
Which one of the following donors would be expected to elicit apo
n n n n n n n n n n n n
sitive mixed lymphocyte response in lymphocytes from a patient
n n n n n n n n n
who has the HLA - DRB1 * 01 : 01 01:03 alleles ?
n n n n n n n n n n n n
c. DRB1 * 01 : 03 , 01:03
n n n n n n n
14. Which of the following HLA antigens would be ex pected toeli
n n n n n n n n n n n n
cit an HLA antibody response in a kidney transplant recipientwit
n n n n n n n n n n
h the following HLA type : HLA - A 01,03 ; B 07,14 ; C 01,04N
n n n n n n n n n n n n n n n
; DRB1 16,07 ?
n n n
c . HLA - C * 04
n n n n n n
syngeneic graft n
isograft; identical twins n n
, allograft
transplantation of healthy tissue from one person to anotherpers
n n n n n n n n n
on; also called homograft
n n n
same species n
xenograft
transplantation (dermis only) from a foreign donor (usually ap
n n n n n n n n n
ig) and transferred to a human; also called heterograft
n n n n n n n n
Direct allorecognition
n
recipient cytotoxic T cells from host bind and respond directlyt
n n n n n n n n n n
o foreign (allo) HLA proteins MHC I on graft cells.
n n n n n n n n n
CD8
mixed lymphocyte reaction (MLR)
n n n
in vitro reaction of alloreactive T cells from one individual agai
n n n n n n n n n n
nst major histocompatibility complex (MHC) antigens onbloo
n n n n n n n
d cells from another individual
n n n n
